Gerald Chan
Trustee
Description:
Dr. Chan co-founded Morningside, a diversified investment group engaged primarily in private equity and venture capital investments in North America, Asia and Europe. Morningside commenced investing in China in 1992 and remains active in China’s internet, media and life sciences sectors. Dr. Chan is a director of publicly listed Hang Lung Group Limited, a Hong Kong property holding company, and serves on the boards of several private biotechnology companies including CellCentric, Stealth Peptides, and Vaccine Technologies Inc. Dr. Chan is a trustee of Fudan University in Shanghai and sits on many advisory boards such as the International Society of Stem Cell Research Global Advisory Council, Cold Spring Harbor Conferences Asia, International Board of Governors of the New York Academy of Sciences and the Physical Sciences Visiting Committee of UCLA. Dr. Chan received his BS and MS degrees in Engineering from UCLA, and a Master of Science degree in Medical Radiological Physics and a Doctor of Science degree in Radiation Biology from Harvard University. He completed his post-doctoral training at the Dana Farber Cancer Institute.
Summary:
Dr. Chan co-founded Morningside, a diversified investment group engaged primarily in private equity and venture capital investments in North...
Number of Registered Investments:2
Contact Details:
- Find the location here
- No email is provided
Find more here
Email is Not Provided
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.
English 
Polish 